Johnson & Johnson to launch on TrumpRx with 4 of its prescription drugs

robot
Abstract generation in progress

Johnson & Johnson will begin marketing four of its prescription medications on the Trump administration’s TrumpRx website, a move stemming from a voluntary agreement made in January. This partnership allows J&J to lower costs for Americans through Medicaid access and market drugs on TrumpRx, in exchange for exemption from the president’s tariff agenda. The drugs include metformin, Invokana, and Xarelto, doubling the number of medications available on the low-cost site; however, these prices are only accessible to uninsured patients or those whose insurance does not cover the prescriptions.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin